Skip to search formSkip to main contentSkip to account menu

amdoxovir

Known as: 2,6-diaminopurine dioxolane, 4-(2,6-diamino-9H-purin-9-yl)-1,3,-dioxolane-2-methanol 
A nucleoside reverse transcriptase inhibitor prodrug analog of guanosine.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Background Amdoxovir acts synergistically with zidovudine in vitro and the combination prevents or delays the selection of… 
2007
2007
Objective:We evaluated the safety, tolerability and antiretroviral activity of β-D-2,6-diaminopurine dioxolane (DAPD; amdoxovir… 
2005
2005
Objectives:To evaluate the pharmacodynamics and safety of escalating doses of amdoxovir (DAPD) monotherapy administered to… 
Review
2005
Review
2005
Background Amdoxovir (2,6-diaminopurine dioxolane; DAPD) is a nucleoside reverse transcriptase inhibitor (NRTI) of human… 
2003
2003
The frequency of human immunodeficiency virus, type 1 (HIV-1) mutations in response to antiviral therapy and resulting drug… 
Highly Cited
2002
Highly Cited
2002
Summary: Amdoxovir ([‐]‐&bgr;‐D‐2,6‐diaminopurine dioxolane [DAPD]) is a nucleoside reverse transcriptase inhibitor (NRTI) with… 
Highly Cited
2002
Highly Cited
2002
ABSTRACT Removal of nucleoside chain terminator inhibitors mediated by human immunodeficiency virus (HIV) reverse transcriptase… 
2002
2002
In order to understand molecular mechanism of antiviral drug resistance of HIV-1 reverse transcriptase (RT) as well as potent… 
1999
1999
DXG and its prodrug DAPD have been demonstrated to be effective inhibitors of HIV-1 in various cells. The EC50s for DXG were 0…